Developing the subspecialty of cardio-nephrology: The time has come. A position paper from the coordinating committee from the Working Group for Cardiorenal Medicine of the Spanish Society of Nephrology

Herzog, 2011, Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, 80, 572, 10.1038/ki.2011.223 Wang, 2016, The economic burden of chronic kidney disease and end-stage renal disease, Semin Nephrol, 36, 319, 10.1016/j.semnephrol.2016.05.008 Bello, 2017, Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action, Kidney Int Suppl, 7, 122, 10.1016/j.kisu.2017.07.007 Levin, 2017, Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy, Lancet, 390, 1888, 10.1016/S0140-6736(17)30788-2 Rangaswami, 2019, Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association, Circulation, 139, e840, 10.1161/CIR.0000000000000664 Rondeau, 2019, Challenges and opportunities for nephrology in Western Europe, Kidney Int, 95, 1037, 10.1016/j.kint.2018.09.028 Piepoli, 2016, Eur Heart J, 37, 2315, 10.1093/eurheartj/ehw106 Major, 2018, Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis, PLoS ONE, 13, e0192895, 10.1371/journal.pone.0192895 Gorostidi, 2018, Chronic kidney disease in Spain: prevalence and impact of accumulation of cardiovascular risk factors, Nefrología, 38, 606, 10.1016/j.nefro.2018.04.004 McClellan, 2004, Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease, J Am Soc Nephrol, 15, 1912, 10.1097/01.ASN.0000129982.10611.4C George, 2017, Heart failure increases the risk of adverse renal outcomes in patients with normal kidney function, Circ Heart Fail, 10, e003825, 10.1161/CIRCHEARTFAILURE.116.003825 Couser, 2011, The contribution of chronic kidney disease to the global burden of major noncommunicable diseases, Kidney Int, 80, 1258, 10.1038/ki.2011.368 2020, Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 395, 709, 10.1016/S0140-6736(20)30045-3 2017, Global cardiovascular and renal outcomes of reduced GFR, J Am Soc Nephrol, 28, 2167, 10.1681/ASN.2016050562 Paneni, 2017, The aging cardiovascular system: understanding it at the cellular and clinical levels, J Am Coll Cardiol, 69, 1952, 10.1016/j.jacc.2017.01.064 Foley, 1998, Clinical epidemiology of cardiovascular disease in chronic renal disease, Am J Kidney Dis, 32, S112, 10.1053/ajkd.1998.v32.pm9820470 Saran, 2017, US renal data system 2016 annual data report: epidemiology of kidney disease in the United States, Am J Kidney Dis, 69, A7, 10.1053/j.ajkd.2016.12.004 Levey, 2007, Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes, Kidney Int, 72, 247, 10.1038/sj.ki.5002343 Nichols, 2020, Health care costs by type of expenditure across eGFR stages among patients with and without diabetes, cardiovascular disease, and heart failure, J Am Soc Nephrol, 31, 1594, 10.1681/ASN.2019121308 Schrauben, 2020, Hospitalizations among adults with chronic kidney disease in the United States: a cohort study, PLoS Med, 17, e1003470, 10.1371/journal.pmed.1003470 Kent, 2015, What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?, BMC Nephrol, 16, 65, 10.1186/s12882-015-0054-0 Sicras Mainar, 2016, Economic impact of heart failure according to the effects of kidney failure, Rev Esp Cardiol, 68, 39, 10.1016/j.recesp.2014.02.023 Keith, 2004, Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization, Arch Intern Med, 164, 659, 10.1001/archinte.164.6.659 Valdivielso, 2019, Atherosclerosis in chronic kidney disease: more, less, or just different?, Arterioscler Thromb Vasc Biol, 39, 1938, 10.1161/ATVBAHA.119.312705 Betriú, 2014, Investigators from the NEFRONA Study Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study, Nephrol Dial Transplant, 29, 1415, 10.1093/ndt/gfu038 House, 2019, Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, 95, 1304, 10.1016/j.kint.2019.02.022 House, 2012, Cardio-renal syndrome type 4: epidemiology, pathophysiology and treatment, Semin Nephrol, 32, 40, 10.1016/j.semnephrol.2011.11.006 Takahama, 2017, Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets, Am J Physiol Heart Circ Physiol, 313, H715, 10.1152/ajpheart.00215.2017 Liu, 2019, Heart-kidney interactions: mechanistic insights from animal models, Am J Physiol Renal Physiol, F974, 10.1152/ajprenal.00624.2017 Getz, 2012, Animal models of aterosclerosis, Arterioscler Thromb Vasc Biol, 32, 1104, 10.1161/ATVBAHA.111.237693 Wang, 2019, Evolving concepts in the pathogenesis of uraemic cardiomyopathy, Nat Rev Nephrol, 15, 159, 10.1038/s41581-018-0101-8 Briet, 2012, Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications, Clin Sci (Lond), 123, 399, 10.1042/CS20120074 Savira, 2020, Cardiorenal syndrome: multi-organ dysfunction involving the heart, kidney and vasculature, Br J Pharmacol, 177, 2906, 10.1111/bph.15065 Menon, 2005, Cardiovascular risk factors in chronic kidney disease, Kidney Int, 68, 1413, 10.1111/j.1523-1755.2005.00551.x Wanner, 2016, The heart and vascular system in dialysis, Lancet, 388, 276, 10.1016/S0140-6736(16)30508-6 Sarnak, 2019, Chronic kidney disease and coronary artery disease: JACC state-of-the-art review, J Am Coll Cardiol, 74, 1823, 10.1016/j.jacc.2019.08.1017 Querfeld, 2020, Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity, Clin Sci (Lond), 134, 1333, 10.1042/CS20200279 Amann, 2002, Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure, Kidney Int, 62, 877, 10.1046/j.1523-1755.2002.00518.x Charytan, 2014, Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease, Int J Cardiol, 176, 99, 10.1016/j.ijcard.2014.06.062 Prommer, 2018, Chronic kidney disease induces a systemic microangiopathy, tissue hypoxia and dysfunctional angiogénesis, Sci Rep, 8, 5317, 10.1038/s41598-018-23663-1 Kaesler, 2020, Cardiac remodeling in chronic kidney disease, Toxins (Basel), 12, 161, 10.3390/toxins12030161 Izumaru, 2019, Reduced estimated GFR and cardiac remodeling: a population-based autopsy study, Am J Kidney Dis, 74, 373, 10.1053/j.ajkd.2019.02.013 Hulshoff, 2018, Causal connections from chronic kidney disease to cardiac fibrosis, Semin Nephrol, 38, 629, 10.1016/j.semnephrol.2018.08.007 Zannad, 2018, Cardiorenal syndrome revisited, Circulation, 138, 929, 10.1161/CIRCULATIONAHA.117.028814 Romero-González, 2020, Heart failure in chronic kidney disease: the emerging role of myocardial fibrosis, Nephrol Dial Transplant, gfaa284 Bagshaw, 2013, Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations, Contrib Nephrol, 182, 137, 10.1159/000349971 Odutayo, 2017, AKI and long-term risk for cardiovascular events and mortality, J Am Soc Nephrol, 28, 377, 10.1681/ASN.2016010105 Legrand, 2020, Cardiovascular consequences of acute kidney injury, N Engl J Med, 382, 2238, 10.1056/NEJMra1916393 Sosnov, 2006, Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective, Am J Kidney Dis, 47, 378, 10.1053/j.ajkd.2005.11.017 Karthikeyan, 2009, Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation, Curr Cardiol Rev, 5, 177, 10.2174/157340309788970342 Schmidt, 2001, Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy, Am J Kidney Dis, 37, 56, 10.1053/ajkd.2001.20584 Freda, 2002, Cardiac troponins in renal insufficiency: review and clinical implications, J Am Coll Cardiol, 40, 2065, 10.1016/S0735-1097(02)02608-6 Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Di Lullo, 2015, Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment, Cardiorenal Med, 5, 254, 10.1159/000435838 Maisel, 2008, State of the art: using natriuretic peptide levels in clinical practice, Eur J Heart Fail, 10, 824, 10.1016/j.ejheart.2008.07.014 Maini, 2018, Persistent underrepresentation of kidney disease in randomized, controlled trials of cardiovascular disease in the contemporary era, J Am Soc Nephrol, 29, 2782, 10.1681/ASN.2018070674 Carpenter, 2012, Inadequacy of cardiovascular risk factor management in chronic kidney transplantation – evidence from the FAVORIT study, Clin Transplant, 26, E438, 10.1111/j.1399-0012.2012.01676.x Zannad, 2017, Cardiovascular outcome trials in patients with advanced kidney disease: time for action, Circulation, 135, 1769, 10.1161/CIRCULATIONAHA.117.027338 Konstantinidis, 2016, Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review, JAMA Intern Med, 176, 121, 10.1001/jamainternmed.2015.6102 Rossignol, 2019, Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints, Eur Heart J, 40, 880, 10.1093/eurheartj/ehx209 O’Lone, 2018, Cardiovascular outcomes reported in hemodialysis trials, J Am Coll Cardiol, 71, 2802, 10.1016/j.jacc.2018.04.012 Romero-González, 2020, Burden and challenges of heart failure in patients with chronic kidney disease. A call to action, Nefrología, 40, 223, 10.1016/j.nefro.2019.10.005 Foley, 1995, Clinical and echocardiographic disease in patients starting end-stage renal disease therapy, Kidney Int, 47, 186, 10.1038/ki.1995.22 Cheung, 2004, Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study, Kidney Int, 65, 2380, 10.1111/j.1523-1755.2004.00657.x Lozier, 2019, Comparison of cardiovascular outcomes by dialysis modality: a systematic review and meta-analysis, Perit Dial Int, 39, 306, 10.3747/pdi.2018.00227 Ng, 2020, Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis, Int Urol Nephrol Arend, 1997, Patient survival after renal transplantation; more than 25 years follow-up, Nephrol Dial Transplant, 12, 1672, 10.1093/ndt/12.8.1672 Ojo, 2000, Long-term survival in renal transplant recipients with graft function, Kidney Int, 57, 307, 10.1046/j.1523-1755.2000.00816.x Rangaswami, 2019, Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies, Nephrol Dial Transplant, 34, 760, 10.1093/ndt/gfz053 Shaikh, 2020, Current paradigms and emerging opportunities in nephrology training, Adv Chronic Kidney Dis, 27, 291, 10.1053/j.ackd.2020.05.011 Rope, 2017, Education in nephrology fellowship: a survey-based needs assessment, J Am Soc Nephrol, 28, 1983, 10.1681/ASN.2016101061 Tonelli, 2018, Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system, JAMA Netw Open, 1, e184852, 10.1001/jamanetworkopen.2018.4852 Sachdeva, 2020, Opportunities for subspecialization in nephrology, Adv Chronic Kidney Dis, 27, 320, 10.1053/j.ackd.2020.05.002 Kazory, 2018, Cardionephrology: proposal for a futuristic educational approach to a contemporary need, Cardiorenal Med, 8, 296, 10.1159/000490744 Rangaswami, 2018, Resuscitation for the specialty of nephrology: is cardionephrology the answer?, Kidney Int, 93, 25, 10.1016/j.kint.2017.10.002 Covic, 2009, NDT Plus, 2, 522 Cardio Renal Society of America. 2010. https://www.cardiorenalsociety.org. Ronco, 2017, A call to action to develop integrated curricula in cardiorenal medicine, Blood Purif, 44, 251, 10.1159/000480318 Koratala, 2019, Integrating point-of-care ultrasonography into nephrology fellowship training: a model curriculum, Am J Kidney Dis, 74, 1, 10.1053/j.ajkd.2019.02.002 Chawla, 2014, Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup, J Am Coll Cardiol, 63, 1246, 10.1016/j.jacc.2014.01.020 Mullens, 2020, Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail, 22, 584, 10.1002/ejhf.1697 Verbrugge, 2020, Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney, Circulation, 142, 998, 10.1161/CIRCULATIONAHA.119.045409 Virzì, 2019, Multi-omics approach: new potential key mechanisms implicated in cardiorenal syndromes, Cardiorenal Med, 9, 201, 10.1159/000497748 Kanbay, 2019, A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease, Clin Kidney J, 12, 861, 10.1093/ckj/sfz106 Baigent, 2017, Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, 92, 297, 10.1016/j.kint.2017.04.019 Rangaswami, 2020, Cardio-renal-metabolic care models toward achieving effective interdisciplinary care, Circ Cardiovasc Qual Outcomes, 13, e007264, 10.1161/CIRCOUTCOMES.120.007264 Agrawal, 2011, Identification and management of chronic kidney disease complications by internal medicine residents: a national survey, Am J Ther, 18, e40, 10.1097/MJT.0b013e3181bbf6fc Agarwal, 2009, Perception of indications for nephrology referral among internal medicine residents: a national online survey, Clin J Am Soc Nephrol, 4, 323, 10.2215/CJN.03510708 Agarwal, 2008, Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey, Am J Kidney Dis, 52, 1061, 10.1053/j.ajkd.2008.06.022 Boorsma, 2020, Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment, Nat Rev Cardiol, 17, 641, 10.1038/s41569-020-0379-7 de Ruiter, 2020, Fluid management in chronic kidney disease: what is too much, what is the distribution, and how to manage fluid overload in patients with chronic kidney disease?, Curr Opin Nephrol Hypertens, 29, 572, 10.1097/MNH.0000000000000640 Zelniker, 2020, Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review, J Am Coll Cardiol, 75, 422, 10.1016/j.jacc.2019.11.031 Zelniker, 2020, Clinical benefit of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review, J Am Coll Cardiol, 75, 435, 10.1016/j.jacc.2019.11.036 Sankaranarayanan, 2020, Cardio-nephrology MDT meetings play an important role in the management of cardiorenal síndrome, Br J Cardiol, 27, 80 Bright, 1836, Cases and observations illustrative of renal disease accompanied by the secretion of albuminous urine, Guys Hospital Rep, 338